We are seeking an enthusiastic, proactive, and collaborative radiochemist to join Professor Witney’s Group in the School of Biomedical Engineering & Imaging Sciences, King’s College London. You will join a dynamic and successful molecular imaging Team with access to both extensive organic and radiochemistry facilities, and world-renowned expertise. Together, we are developing next-generation radiotheranostics to detect and treat therapy-resistant cancer (see www.witneylab.com for more details). We are committed to improving patient outcomes through commercialisation of our agents (www.nuclidetx.com) and by leading clinical trials (e.g. NCT05889312). 

 

Our Group has a track record of research excellence, substantial grant funding, and awards (e.g. World Molecular Imaging Congress’ Young Investigator of the Year Award, CME postdoctoral Fellowship). We are dedicated to supporting the successful candidate’s career through assistance with Fellowship applications, networking events, and attendance at international conferences.  

 

Working in collaboration with biologists and molecular imaging scientists, the successful candidate will develop radionuclide-based molecular imaging and radionuclide therapies for the detection and treatment of drug-resistant cancer (‘radiotheranostics’). You will develop new chemistry and novel fluorine-18 labelled radiotracers for imaging with positron emission tomography (PET) and therapeutic radionuclide therapies labelled with iodine-131 to support this programme of research. As part of the wider aims of the lab, you will support the radiolabelling of other radiotheranostics using zirconium-89 and lutetium-177. In collaboration with the new GMP radiochemistry facility at KCL (PERL), we will translate these novel imaging methods to the clinic. Support will be provided for you to take the project in new and interesting directions.

 

You will manage your own research and administrative activities, within guidelines provided by the PI and in collaboration with senior colleagues, and contribute to wider project development and potential commercialisation. You will determine the most appropriate methodologies to test hypotheses and identify suitable alternatives if technical problems arise as well as select, follow, and present scientific data from a variety of sources. You will contribute to discussions and share research findings with colleagues in partner institutions, and research groups.

 

You must have a track record of research achievement (through peer-reviewed publications) and hold a PhD in synthetic or radio-chemistry, be self-motivated, able to work independently, and have excellent written and verbal communication skills. Applicants with a keen interest in chemical biology and multidisciplinary research are especially encouraged to apply.

 

This is a full time post (35 Hours per week), and you will be offered a fixed term contract until 31 December 2027.